Aehr Test Systems, Inc.
AEHRTechnologyNASDAQSemiconductor Equipment & Materials
Scan Results
Daily timeframeAehr Test Systems, Inc. provides test solutions for testing, burning-in, and semiconductor devices in wafer level, singulated die, package part form, and installed systems in the United States, Asia, and Europe. Valued at $2.90B, AEHR is a mid-cap name in its sector. Its product portfolio includes FOX-XP and FOX-NP systems that are full wafer contact and singulated die/module test and burn-in systems that test, burn-in, and stabilize range of devices, including silicon carbide-based and other power semiconductors, 2D, and 3D sensors used in mobile phones, tablets and other computing devices, memory semiconductors, processors, microcontrollers, systems-on-a-chip, and photonics and integrated optical devices.
Market Cap
$2.90B
Beta
3.27
P/E (TTM)
—
P/E (Fwd)
615.53
EPS (TTM)
$-0.38
EPS (Fwd)
$0.15
ROE
-8.7%
ROA
-6.1%
Cash
$36.9M
Total Debt
$10.0M
Free CF
-$7.5M
52W Change
855.8%
Annual Financials
Cash vs Debt
With $36.9M in cash and $10.0M in debt, AEHR maintains more liquidity than leverage. This favorable balance sheet position can be an asset when capital markets become less accommodating. Free cash flow is running at -$7.5M, which bears watching. Negative free cash flow can be acceptable during heavy investment periods but needs to improve over time. ROE of -8.7% points to negative capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. Revenue has been uneven over recent years, ranging from $50.8M to $59.0M.
Aehr Test Systems, Inc.'s elevated beta suggests the stock experiences more pronounced price movements than the overall market, which increases both upside potential and downside risk. With cash comfortably exceeding debt, AEHR has financial flexibility that may help navigate uncertain periods. The company is burning cash at the operating level, which is not unusual for growth-phase companies but adds risk if it persists. No single metric tells the full story. Reviewing AEHR's risk profile alongside its fundamentals and technical indicators provides a more complete picture.